Lara Dennie Clark

Lara Dennie Clark has a diverse work experience in the pharmaceutical industry. Their most recent position is as the Senior Director of Program Management at Aditum Bio since May 2021. Prior to that, they worked at DiscGenics as the Senior Director of Clinical, Regulatory Affairs & Quality from April 2020 to May 2021.

From 2016 to 2020, Lara worked at GSK as the Director of Clinical Research Innovation, where they were responsible for designing and delivering clinical development strategies and protocols in various therapeutic areas. Lara also managed cross-functional study teams and ensured the successful execution of clinical studies.

Before their time at GSK, Lara held the position of Principal Clinical Research Scientist at GlaxoSmithKline from August 2015 to October 2016. In this role, they played a key role in developing the clinical innovation pipeline and assessing the probability of clinical success for various programs.

In addition, Lara worked at Pfizer in various roles. Lara was a Senior Manager in Clinical Research for a brief period in 2015 and a Manager in Clinical Research from 2014 to 2015. During their time at Pfizer, they contributed to the submission of the first Direct-to-OTC switch and authored clinical study reports.

Prior to their industry experience, Lara worked as a Post-Doctoral Fellow in Clinical Development at Pfizer Consumer Healthcare from 2012 to 2014. Lara led multi-disciplinary study teams, assisted in designing and implementing clinical studies, and ensured compliance with regulations and timelines.

Lara also gained experience through a rotation in Immuno-Inflammation at sanofi-aventis in 2011 and as a Research Assistant with the Albany Nephrology Pharmacy Group at Albany College of Pharmacy and Health Sciences from 2010 to 2011.

In summary, Lara Dennie Clark has extensive experience in clinical research, program management, regulatory affairs, and quality control within the pharmaceutical industry, working for companies such as Aditum Bio, DiscGenics, GSK, GlaxoSmithKline, Pfizer, and sanofi-aventis.

Lara Dennie Clark pursued their education at Albany College of Pharmacy and Health Sciences from 2006 to 2012. During this period, they obtained their PharmD degree, however, their specific field of study was not provided.